Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors
February 3, 2021
February 3, 2021
January 15, 2021
January 13, 2021
January 12, 2021
January 11, 2021
January 11, 2021
January 7, 2021
December 7, 2020
November 19, 2020
November 10, 2020